Martin J. Madden
Independent DirectorMr. Martin J. Madden served as Director at Ossio Inc. since 2022 until June 2023. He served as Vice President Research & Development for Orthopedics, Global Surgery and Interventional Vascular Divisions at Johnson & Johnson. Mr. Madden retired from Johnson & Johnson after a 30 year career (from 1986 to January 2017), where he served as Vice President of Research & Development for DePuy-Synthes and Vice President of Medical Device R&D Transformation from February 2016 to January 2017, as Vice President of New Product Development for Medical Devices from July 2015 to February 2016 and as Vice President R&D Global Surgery Group from January 2012 to July 2015. Mr. Madden has been Independent Director of TSO3 Inc., since August 29, 2018. Mr. Madden's diversified and extensive R&D experience in the development of medical devices includes hundreds of projects in multiple medical spaces, many of which reached successful commercialization stage. He was a Medical Device Engineer and Innovator and a Leader of cross-functional teams charged with incubating, developing and launching new products. Mr. Madden was an innovator and research leader for nearly every medical device business including cardiology, electrophysiology, peripheral vascular surgery, general and colorectal surgery, aesthetics, orthopedics, sports medicine, spine and trauma. As an Executive and a Vice President of Johnson & Johnson, Mr. Madden served on the management boards of Johnson & Johnson’s Global Surgery Group, Ethicon, Ethicon Endo-Surgery, DePuy-Synthes and Cordis, with responsibility for research and development – inclusive of organic and licensed/acquired technology. He was also Chairman of J&J’s Medical Device Research Council, with responsibility for talent strategy and technology acceleration. He has been an Independent Director at NovoCure Limited since May 10, 2017 and is an advisor to numerous medical device start-ups. He has been Independent Director of Microbot Medical Inc. since February 6, 2017. Mr. Madden holds an MBA from Columbia University, a Master of Science in Mechanical Engineering from Carnegie-Mellon University and Bachelor of Science in Mechanical Engineering from the University of Dayton.
Positions
- Company NameNovoCure LimitedStock CodeNVCRPositionIndependent DirectorColleagues
- Company NameMicrobot Medical Inc.Stock CodeMBOTPositionIndependent DirectorColleagues
- HGHarel GadotCo-Founder, President, CEO & Chairman
- RVRachel VakninChief Financial Officer
- SSSimon SharonCTO & GM of Microbot Israel
- JDJuan Diaz-CartelleChief Medical Officer
- CBChristina BaileyVice President of Sales
- SRScott R. BurellIndependent Director
- MJMartin J. MaddenIndependent Director
- PLPrattipati LaxminarainIndependent Director
- EMEyal MoragMember of Scientific Advisory Board
